This month, we're making a 99-cent donation* to the American Diabetes Association for each unique visitor to this page — supporting health equity for the 99% of people living with diabetes globally who aren't using a continuous glucose monitor (CGM) like FreeStyle Libre technology.1
Every 23 seconds, someone in the U.S. is diagnosed with diabetes.2 Every 23 seconds, someone's life is at a crossroads.
Unlike with traditional blood glucose monitoring, continuous glucose monitoring (CGM) devices, such as the FreeStyle Libre family of products, are small sensor-based systems that provide real-time glucose readings every minute, day and night, without painful fingersticks,3,4 for people living with diabetes. This information can empower people to find greater control over their diabetes management decisions.
The problem? Only 1% of people living with diabetes around the world use CGMs.1
The FreeStyle Libre portfolio is the number one sensor-based glucose monitoring system in the world,5 having changed the lives of over 5 million people across more than 60 countries6 by providing breakthrough technology that is accessible and affordable.7 Yet, millions still don’t know this technology exists. Our automatic donation of 99 cents*, just for your site visit, will go to the American Diabetes Association's Health Equity Now program, which helps more people learn about the vital role technology can play in helping them manage their condition.
DISCLAIMER: The views expressed on this website should not be used for medical diagnosis or treatment or as a substitute for professional medical advice. Individual symptoms, situations and circumstances may vary. Sherri Shepherd is a paid ambassador for FreeStyle Libre portfolio.
* Abbott will donate $0.99 to the American Diabetes Association’s (ADA) Health Equity Now (HEN) program for every unique visit to its Countdown at a Crossroads website (www.Crossroads.Abbott) from November 1–30, 2023, 11:59:59 PM ET, up to $100,000.
2 Research is the Key to Ending Diabetes. American Diabetes Association. Accessed September 27, 2023. https://diabetes.org/ways-to-give/donations.
3 FreeStyle Libre 14 day system: Fingersticks are required for treatment decisions when you see Check Blood Glucose symbol, when symptoms do not match system readings, when you suspect readings may be inaccurate, or when you experience symptoms that may be due to high or low blood glucose.
4 FreeStyle Libre 2 and FreeStyle Libre 3 systems: Fingersticks are required if your glucose alarms and readings do not match symptoms or when you see Check Blood Glucose symbol during the first 12 hours.
5 Data based on the number of users worldwide for FreeStyle Libre family of personal CGMs compared to the number of users for other leading personal CGM brands and based on CGM sales dollars compared to other leading personal CGM brands.
6 Data on file, Abbott Diabetes Care.
7 Based on a comparison of list prices of the FreeStyle Libre 14-day, FreeStyle Libre 2, and FreeStyle Libre 3 systems versus competitors' CGM systems, assuming annual use of one receiver (or equivalent hardware) and quantity of transmitters and/or sensors according to use life. The actual cost to patients may or may not be lower than other CGM systems, depending on the amount covered by insurance, if any.
8 Eligible patients will receive one (1) FreeStyle Libre 2 sensor for users with a compatible mobile phone operating system at $0 copay. The expiration date of the voucher is 60 days from the issue date. This program is available for patients with Type 1 or Type 2 diabetes; it is not available for patients with gestational diabetes. Only patients ages 18 and older are eligible to sign up and receive an offer for the FreeStyle Libre 2 sensor and patients ages 4-17 are eligible to receive an offer for the FreeStyle Libre 2 sensor through their parent or guardian. This offer is void where prohibited by law. Abbott may modify or rescind this offer at any time without notice. The discounts are not available to beneficiaries of Medicare, Medicaid or other federal or state healthcare programs or residents of Massachusetts, Puerto Rico and other US territories. The free FreeStyle Libre 2 sensor is provided as a sample and is limited to one NDC per eligible person. The FreeStyle Libre 2 sensor cannot be re-sold, traded
9 Diabetes complications: Diabetes & DKA (Ketoacidosis). American Diabetes Association. Accessed September 27, 2023. https://diabetes.org/diabetes/dka-ketoacidosis-ketones.
10 Diabetes and Hispanic Americans. U.S. Department of Health and Human Services. Accessed October 3, 2023. https://minorityhealth.hhs.gov/diabetes-and-hispanic-americans
11 The LibreView data management software is intended for use by both patients and healthcare professionals to assist people with diabetes and their healthcare professionals in the review, analysis and evaluation of historical glucose meter data to support effective diabetes management. The LibreView software is not intended to provide treatment decisions or to be used as a substitute for professional healthcare advice.
IMPORTANT SAFETY INFORMATION
FreeStyle Libre 14 day, FreeStyle Libre 2 and FreeStyle Libre 3 systems
Failure to use FreeStyle Libre systems as instructed in labeling may result in missing a severe low or high glucose event and/or making a treatment decision, resulting in injury. If glucose reading and alarms (if enabled) do not match symptoms or expectations, use a fingerstick value from a blood glucose meter for treatment decisions. Seek medical attention when appropriate or contact Abbott at 855-632-8658 or FreeStyleLibre.us for safety info.
FreeStyle Libre Customer Service
People in the U.S. who have questions about the FreeStyle Libre portfolio can reach out to Abbott's Customer Service toll-free at 855-632-8658. Agents are available seven days a week from 8 a.m. to 8 p.m. Eastern Time, excluding holidays.